OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Impact of the COVID ‐19 pandemic on hospital admissions of patients with rare diseases: an experience of a Southern Italy referral center
Fabrizio Martora, Gabriella Fabbrocini, Paola Nappa, et al.
International Journal of Dermatology (2022) Vol. 61, Iss. 7
Open Access | Times Cited: 33
Fabrizio Martora, Gabriella Fabbrocini, Paola Nappa, et al.
International Journal of Dermatology (2022) Vol. 61, Iss. 7
Open Access | Times Cited: 33
Showing 1-25 of 33 citing articles:
Fabrizio Martora, Alessia Villani, Gabriella Fabbrocini, et al.
Journal of Cosmetic Dermatology (2022) Vol. 22, Iss. 1, pp. 4-10
Open Access | Times Cited: 37
The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review
Angelo Ruggiero, Fabrizio Martora, Gabriella Fabbrocini, et al.
Clinical Cosmetic and Investigational Dermatology (2022) Vol. Volume 15, pp. 2785-2793
Open Access | Times Cited: 36
Angelo Ruggiero, Fabrizio Martora, Gabriella Fabbrocini, et al.
Clinical Cosmetic and Investigational Dermatology (2022) Vol. Volume 15, pp. 2785-2793
Open Access | Times Cited: 36
Management of patients with hidradenitis suppurativa during COVID-19 vaccination: an experience from southern Italy. Comment on: ‘Evaluating the safety and efficacy of COVID-19 vaccination in patients with hidradenitis suppurativa’
Fabrizio Martora, Claudio Marasca, Teresa Battista, et al.
Clinical and Experimental Dermatology (2022) Vol. 47, Iss. 11, pp. 2026-2028
Open Access | Times Cited: 25
Fabrizio Martora, Claudio Marasca, Teresa Battista, et al.
Clinical and Experimental Dermatology (2022) Vol. 47, Iss. 11, pp. 2026-2028
Open Access | Times Cited: 25
Guselkumab, Risankizumab, and Tildrakizumab in the Management of Hidradenitis Suppurativa: A Review of Existing Trials and Real-Life Data
Fabrizio Martora, Massimiliano Scalvenzi, Teresa Battista, et al.
Clinical Cosmetic and Investigational Dermatology (2023) Vol. Volume 16, pp. 2525-2536
Open Access | Times Cited: 14
Fabrizio Martora, Massimiliano Scalvenzi, Teresa Battista, et al.
Clinical Cosmetic and Investigational Dermatology (2023) Vol. Volume 16, pp. 2525-2536
Open Access | Times Cited: 14
Pityriasis Rosea and Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination: A Narrative Review
Luca Potestio, Fabrizio Martora, Sara Cacciapuoti, et al.
Clinical Cosmetic and Investigational Dermatology (2024) Vol. Volume 17, pp. 51-57
Open Access | Times Cited: 4
Luca Potestio, Fabrizio Martora, Sara Cacciapuoti, et al.
Clinical Cosmetic and Investigational Dermatology (2024) Vol. Volume 17, pp. 51-57
Open Access | Times Cited: 4
The Past, the Present and the Future of Teledermatology: A Narrative Review
Nello Tommasino, Matteo Megna, Sara Cacciapuoti, et al.
Clinical Cosmetic and Investigational Dermatology (2024) Vol. Volume 17, pp. 717-723
Open Access | Times Cited: 4
Nello Tommasino, Matteo Megna, Sara Cacciapuoti, et al.
Clinical Cosmetic and Investigational Dermatology (2024) Vol. Volume 17, pp. 717-723
Open Access | Times Cited: 4
Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature
Fabrizio Martora, Teresa Battista, Claudio Marasca, et al.
Clinical Cosmetic and Investigational Dermatology (2022) Vol. Volume 15, pp. 2369-2382
Open Access | Times Cited: 17
Fabrizio Martora, Teresa Battista, Claudio Marasca, et al.
Clinical Cosmetic and Investigational Dermatology (2022) Vol. Volume 15, pp. 2369-2382
Open Access | Times Cited: 17
A shock to the (health) system: experiences of adults with rare disorders during the first COVID-19 wave
Kathleen R. Bogart, A. Hartinger, M Klaus, et al.
Orphanet Journal of Rare Diseases (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 3
Kathleen R. Bogart, A. Hartinger, M Klaus, et al.
Orphanet Journal of Rare Diseases (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 3
Teledermatology for Common Inflammatory Skin Conditions: The Medicine of the Future?
Fabrizio Martora, Gabriella Fabbrocini, Matteo Megna, et al.
Life (2023) Vol. 13, Iss. 4, pp. 1037-1037
Open Access | Times Cited: 8
Fabrizio Martora, Gabriella Fabbrocini, Matteo Megna, et al.
Life (2023) Vol. 13, Iss. 4, pp. 1037-1037
Open Access | Times Cited: 8
Viral reactivation following COVID-19 vaccination: a review of the current literature
Fabrizio Martora, Matteo Megna, Teresa Battista, et al.
Clinical and Experimental Dermatology (2024) Vol. 49, Iss. 6, pp. 556-565
Closed Access | Times Cited: 2
Fabrizio Martora, Matteo Megna, Teresa Battista, et al.
Clinical and Experimental Dermatology (2024) Vol. 49, Iss. 6, pp. 556-565
Closed Access | Times Cited: 2
The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature
Fabrizio Martora, Teresa Battista, Angelo Ruggiero, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1423-1423
Open Access | Times Cited: 6
Fabrizio Martora, Teresa Battista, Angelo Ruggiero, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1423-1423
Open Access | Times Cited: 6
Herpes Zoster and COVID-19 Vaccination: A Narrative Review
Luca Potestio, Matteo Megna, Alessia Villani, et al.
Clinical Cosmetic and Investigational Dermatology (2023) Vol. Volume 16, pp. 3323-3331
Open Access | Times Cited: 6
Luca Potestio, Matteo Megna, Alessia Villani, et al.
Clinical Cosmetic and Investigational Dermatology (2023) Vol. Volume 16, pp. 3323-3331
Open Access | Times Cited: 6
Efficacy and safety of spesolimab for the management of generalized pustular psoriasis: a drug safety evaluation
Luca Potestio, Elisa Camela, Sara Cacciapuoti, et al.
Expert Opinion on Drug Safety (2023) Vol. 22, Iss. 11, pp. 1003-1010
Closed Access | Times Cited: 4
Luca Potestio, Elisa Camela, Sara Cacciapuoti, et al.
Expert Opinion on Drug Safety (2023) Vol. 22, Iss. 11, pp. 1003-1010
Closed Access | Times Cited: 4
Herpes zoster and alopecia areata following mRNA BNT162b2 COVID ‐19 vaccine: Controversial immune effects
Fabrizio Martora, Luigi Fornaro, Vincenzo Picone, et al.
Journal of Cosmetic Dermatology (2022) Vol. 22, Iss. 1, pp. 36-38
Open Access | Times Cited: 7
Fabrizio Martora, Luigi Fornaro, Vincenzo Picone, et al.
Journal of Cosmetic Dermatology (2022) Vol. 22, Iss. 1, pp. 36-38
Open Access | Times Cited: 7
Concomitant Severe Psoriasis and Bullous Pemphigoid Induced by COVID-19
Fabrizio Martora, Teresa Battista, Gabriella Fabbrocini, et al.
Tropical Medicine and Infectious Disease (2023) Vol. 8, Iss. 2, pp. 107-107
Open Access | Times Cited: 3
Fabrizio Martora, Teresa Battista, Gabriella Fabbrocini, et al.
Tropical Medicine and Infectious Disease (2023) Vol. 8, Iss. 2, pp. 107-107
Open Access | Times Cited: 3
The Experience of a Tertiary Reference Hospital in the Study of Rare Neurological Diseases
Styliani-Aggeliki Sintila, Marina Boziki, Christos Bakirtzis, et al.
Medicina (2023) Vol. 59, Iss. 2, pp. 266-266
Open Access | Times Cited: 3
Styliani-Aggeliki Sintila, Marina Boziki, Christos Bakirtzis, et al.
Medicina (2023) Vol. 59, Iss. 2, pp. 266-266
Open Access | Times Cited: 3
Safety and Efficacy of Covid-19 Vaccination in Patients Undergoing Biological Treatments for Psoriasis
Luca Potestio, Fabrizio Martora, Gabriella Fabbrocini, et al.
Psoriasis Targets and Therapy (2023) Vol. Volume 13, pp. 11-18
Open Access | Times Cited: 3
Luca Potestio, Fabrizio Martora, Gabriella Fabbrocini, et al.
Psoriasis Targets and Therapy (2023) Vol. Volume 13, pp. 11-18
Open Access | Times Cited: 3
Advancing dermatology: embracing the power of artificial intelligence. Comment on ‘Artificial intelligence-assisted publishing in five prominent dermatology journals: a quantitative study of recent publications’
Luca Potestio, Fabrizio Martora, Alessia Villani, et al.
Clinical and Experimental Dermatology (2023) Vol. 49, Iss. 7, pp. 730-731
Closed Access | Times Cited: 3
Luca Potestio, Fabrizio Martora, Alessia Villani, et al.
Clinical and Experimental Dermatology (2023) Vol. 49, Iss. 7, pp. 730-731
Closed Access | Times Cited: 3
Patient satisfaction with remote dermatology consultations during the COVID-19 pandemic. Comment on ‘A qualitative assessment of patient satisfaction with remote dermatology consultations used during the UK's first wave of the COVID-19 pandemic in a single, secondary-care dermatology department’
Fabrizio Martora, Angelo Ruggiero, Gabriella Fabbrocini, et al.
Clinical and Experimental Dermatology (2022) Vol. 47, Iss. 11, pp. 2037-2038
Open Access | Times Cited: 5
Fabrizio Martora, Angelo Ruggiero, Gabriella Fabbrocini, et al.
Clinical and Experimental Dermatology (2022) Vol. 47, Iss. 11, pp. 2037-2038
Open Access | Times Cited: 5
Bullous pemphigoid and COVID ‐19 vaccination: Management and treatment reply to ‘Bullous pemphigoid in a young male after COVID ‐19 mRNA vaccine: A report and brief literature review’ by Pauluzzi et al.
Fabrizio Martora, Angelo Ruggiero, Teresa Battista, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 37, Iss. 1
Open Access | Times Cited: 4
Fabrizio Martora, Angelo Ruggiero, Teresa Battista, et al.
Journal of the European Academy of Dermatology and Venereology (2022) Vol. 37, Iss. 1
Open Access | Times Cited: 4
Epidermolysis bullosa: new insights for the future
Fabrizio Martora, Gabriella Fabbrocini, Teresa Battista, et al.
Clinical and Experimental Dermatology (2022) Vol. 47, Iss. 12, pp. 2287-2288
Closed Access | Times Cited: 3
Fabrizio Martora, Gabriella Fabbrocini, Teresa Battista, et al.
Clinical and Experimental Dermatology (2022) Vol. 47, Iss. 12, pp. 2287-2288
Closed Access | Times Cited: 3
Pemphigus vulgaris and COVID ‐19 vaccination: Management and treatment
Fabrizio Martora, Teresa Battista, Paola Nappa, et al.
Journal of Cosmetic Dermatology (2022) Vol. 22, Iss. 1, pp. 30-31
Open Access | Times Cited: 3
Fabrizio Martora, Teresa Battista, Paola Nappa, et al.
Journal of Cosmetic Dermatology (2022) Vol. 22, Iss. 1, pp. 30-31
Open Access | Times Cited: 3
The impact of COVID-19 pandemic on dermatology patients with rare skin diseases
Migena Vargu, Sabina Dedej, Ermira Vasili
Dermatology Reports (2024)
Open Access
Migena Vargu, Sabina Dedej, Ermira Vasili
Dermatology Reports (2024)
Open Access
Exploring teledermatology in managing common inflammatory skin conditions: a systematic review
Şule Gençoğlu
Journal of Health Sciences and Medicine (2024) Vol. 7, Iss. 3, pp. 341-345
Open Access
Şule Gençoğlu
Journal of Health Sciences and Medicine (2024) Vol. 7, Iss. 3, pp. 341-345
Open Access
Pemphigus and Bullous Pemphigoid Following COVID-19 Vaccination: A Systematic Review
Fabrizio Martora, Teresa Battista, Luca Potestio, et al.
Viruses (2024) Vol. 16, Iss. 12, pp. 1896-1896
Open Access
Fabrizio Martora, Teresa Battista, Luca Potestio, et al.
Viruses (2024) Vol. 16, Iss. 12, pp. 1896-1896
Open Access
